ReVision CEO John Kilcoyne Says the Company is Ready to Build a New Medtech Market in Ophthalmology
Aug 11, 2016
27:34
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
ReVision Optics built it – a corneal inlay capable of correcting presbyopia. The FDA approved it sooner than expected. Now the company needs to build it into a successful private-pay business.
Medtech Talk